Joseph E. Bugaj

Novel Receptor-Targeted Fluorescent Contrast Agents for In Vivo Tumor Imaging

Samuel Achilefu, Richard B. Dorshow, Joseph E. Bugaj et al. · Investigative Radiology · 2000 · 312 citations

Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform

Joseph E. Bugaj, Samuel Achilefu, Richard B. Dorshow et al. · Journal of Biomedical Optics · 2001 · 166 citations · Full text

Engineering, Oncologic Imaging, Imaging Agent +17

Synthesis, In Vitro Receptor Binding, and In Vivo Evaluation of Fluorescein and Carbocyanine Peptide-Based Optical Contrast Agents

Samuel Achilefu, Hermo N. Jimenez, Richard B. Dorshow et al. · Journal of Medicinal Chemistry · 2002 · 129 citations · Full text

Engineering, Imaging Agent, Vitro Receptor Binding +16

Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.

Wouter A.P. Breeman, Marion de Jong, Jack L. Erion et al. · PubMed · 2002 · 90 citations

Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo

Jean Claude Reubi, Beatrice Waser, Jean‐Claude Schaer et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1998 · 84 citations

Signal Transduction, Novel Therapy, Functional Selectivity +12